Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations

Keyphrases

• Inflammation 100%
• Cystic Fibrosis 100%
• AE-IPF 100%
• Airway Microbiome 100%
• Pseudomonas 83%
• Pulmonary Exacerbation 66%
• Lung Function 50%
• Sputum 50%
• Relative Abundance 50%
• Quantitative PCR 33%
• Forced Expiratory Volume in 1 Second (FEV1) 33%
• Microbiome Function 33%
• C-reactive Protein 33%
• Airway Inflammation 16%
• Interleukin-8 16%
• Pseudomonas Aeruginosa (P. aeruginosa) 16%
• Airway Infection 16%
• Airway 16%
• Microbiota 16%
• Response to Treatment 16%
• Anaerobic Organism 16%
• Early Treatment 16%
• Treatment Results 16%
• Pyrosequencing 16%
• 16S rRNA Amplicon 16%
• FEV1% Predicted 16%
• Change of Variables 16%
• Variability in Response 16%
• Low Diversity 16%
• Specific Bacteria 16%
• Late Treatment 16%
• Total Bacterial Count 16%
• Neutrophil Elastase 16%
• Lung Function Tests 16%
• Sputum Samples 16%
• Prevotella 16%
• Facultative Anaerobic 16%
• Obligate Anaerobic 16%
• Expectorated Sputum 16%

Immunology and Microbiology

• Pseudomonas 100%
• Microflora 100%
• Sputum 100%
• Airway 100%
• Real-Time Polymerase Chain Reaction 40%
• C-Reactive Protein 40%
• Pyrosequencing 20%
• Anaerobe 20%
• Infectious Agent 20%
• Amplicon 20%
• Pseudomonas aeruginosa 20%
• Prevotella 20%
• Neutrophil 20%
• Interleukin 8 20%
• Infection 20%
• Ribosomal RNA 20%
• Ribosome RNA 20%

Medicine and Dentistry

• Testing Function 11%